Trial · NCT00676403
Results by group792
Each measurement the trial posted, group by group, in the words and numbers it posted.
1 to 20 of 792
Download this page as JSON| Outcome | Group | Category | Value | Spread | Units |
|---|---|---|---|---|---|
| Change From Baseline in Restless Leg Syndrome (RLS) International Restless Leg Group Symptom Severity Rating Scale (IRLS) Total Score at Week 6 | Placebo | -7.73 | Standard Error 1.720 | scores on scale | |
| Change From Baseline in Restless Leg Syndrome (RLS) International Restless Leg Group Symptom Severity Rating Scale (IRLS) Total Score at Week 6 | Pregabalin 50 mg | -11.83 | Standard Error 1.771 | scores on scale | |
| Change From Baseline in Restless Leg Syndrome (RLS) International Restless Leg Group Symptom Severity Rating Scale (IRLS) Total Score at Week 6 | Pregabalin 100 mg | -11.76 | Standard Error 1.694 | scores on scale | |
| Change From Baseline in Restless Leg Syndrome (RLS) International Restless Leg Group Symptom Severity Rating Scale (IRLS) Total Score at Week 6 | Pregabalin 150 mg | -16.02 | Standard Error 1.865 | scores on scale | |
| Change From Baseline in Restless Leg Syndrome (RLS) International Restless Leg Group Symptom Severity Rating Scale (IRLS) Total Score at Week 6 | Pregabalin 300 mg | -12.89 | Standard Error 1.713 | scores on scale | |
| Change From Baseline in Restless Leg Syndrome (RLS) International Restless Leg Group Symptom Severity Rating Scale (IRLS) Total Score at Week 6 | Pregabalin 450 mg | -16.26 | Standard Error 1.771 | scores on scale | |
| Number of Subjects Responding to Treatment as Assessed by the Clinical Global Impression - Improvement Scale (CGI-I) | Placebo | Week 6: Responders (n=21, 20, 22, 18, 23, 20) | 13 | participants | |
| Number of Subjects Responding to Treatment as Assessed by the Clinical Global Impression - Improvement Scale (CGI-I) | Pregabalin 50 mg | Week 6: Responders (n=21, 20, 22, 18, 23, 20) | 12 | participants | |
| Number of Subjects Responding to Treatment as Assessed by the Clinical Global Impression - Improvement Scale (CGI-I) | Pregabalin 100 mg | Week 6: Responders (n=21, 20, 22, 18, 23, 20) | 15 | participants | |
| Number of Subjects Responding to Treatment as Assessed by the Clinical Global Impression - Improvement Scale (CGI-I) | Pregabalin 150 mg | Week 6: Responders (n=21, 20, 22, 18, 23, 20) | 11 | participants | |
| Number of Subjects Responding to Treatment as Assessed by the Clinical Global Impression - Improvement Scale (CGI-I) | Pregabalin 300 mg | Week 6: Responders (n=21, 20, 22, 18, 23, 20) | 17 | participants | |
| Number of Subjects Responding to Treatment as Assessed by the Clinical Global Impression - Improvement Scale (CGI-I) | Pregabalin 450 mg | Week 6: Responders (n=21, 20, 22, 18, 23, 20) | 18 | participants | |
| Number of Subjects Responding to Treatment as Assessed by the Clinical Global Impression - Improvement Scale (CGI-I) | Placebo | Week 6: Non-Responders | 8 | participants | |
| Number of Subjects Responding to Treatment as Assessed by the Clinical Global Impression - Improvement Scale (CGI-I) | Pregabalin 50 mg | Week 6: Non-Responders | 8 | participants | |
| Number of Subjects Responding to Treatment as Assessed by the Clinical Global Impression - Improvement Scale (CGI-I) | Pregabalin 100 mg | Week 6: Non-Responders | 7 | participants | |
| Number of Subjects Responding to Treatment as Assessed by the Clinical Global Impression - Improvement Scale (CGI-I) | Pregabalin 150 mg | Week 6: Non-Responders | 7 | participants | |
| Number of Subjects Responding to Treatment as Assessed by the Clinical Global Impression - Improvement Scale (CGI-I) | Pregabalin 300 mg | Week 6: Non-Responders | 6 | participants | |
| Number of Subjects Responding to Treatment as Assessed by the Clinical Global Impression - Improvement Scale (CGI-I) | Pregabalin 450 mg | Week 6: Non-Responders | 2 | participants | |
| Number of Subjects With Categorical Scores on the Clinical Global Impression - Severity Scale (CGI-S) | Placebo | Baseline: Normal, Not at All Ill | 0 | participants | |
| Number of Subjects With Categorical Scores on the Clinical Global Impression - Severity Scale (CGI-S) | Pregabalin 50 mg | Baseline: Normal, Not at All Ill | 0 | participants |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT00676403/results